FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug
Confidence boost for AI virtual cells for novel target discovery
Anti-fibrotic drug could be repurposed to control cell communication
Positive data from oral therapy designed to improve muscle function and body composition
Rhode Island launches programme to attract life science startups
Novel drug shows promise in an early phase heart failure trial
African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
HiRO and Differentia Biotech look to redefine clinical trial design
Rogue neuronal signal is at the heart of Alzheimer’s disease
Aficamten trial positive for patients with non-obstructive hypertrophic cardiomyopathy
New clues about causes of severe headaches
Base to Base biotech podcast 73: Polymacrocyclic peptides and AI in drug discovery and diagnosis